GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Baolingbao Biology Co Ltd (SZSE:002286) » Definitions » Other Net Income (Loss)

Baolingbao Biology Co (SZSE:002286) Other Net Income (Loss) : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Baolingbao Biology Co Other Net Income (Loss)?

Baolingbao Biology Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0 Mil.

Baolingbao Biology Co's annual Other Net Income (Loss) increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) but then declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil).


Baolingbao Biology Co Other Net Income (Loss) Historical Data

The historical data trend for Baolingbao Biology Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baolingbao Biology Co Other Net Income (Loss) Chart

Baolingbao Biology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Baolingbao Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Baolingbao Biology Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baolingbao Biology Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Baolingbao Biology Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Baolingbao Biology Co (SZSE:002286) Business Description

Traded in Other Exchanges
N/A
Address
NO.1,Dongwaihuan Road, Hi-Tech Development Zone, Yucheng, CHN
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, and syrup series.
Executives
Zhang Guo Gang Directors, executives
Wang Qiang Directors, executives
Huang Yong Qiang Independent director
Jia Wei Chen Supervisors
Zhang Xin Rong Independent director
Liu Zong Li Directors, executives
Liu Feng Directors, executives
Li Xia Directors, executives
Wang Nai Qiang Supervisors
Xue Jian Ping Directors, executives
Yang Yuan Zhi Directors, executives

Baolingbao Biology Co (SZSE:002286) Headlines

No Headlines